Keyphrases
Angiotensin-converting Enzyme Inhibitor (ACEi)
83%
Missense Variants
76%
Statins
74%
Angioedema
66%
Statin Intolerance
66%
Angiotensin Receptor Blockers
59%
Intolerance
49%
Confidence Interval
47%
Meta-analysis
44%
Common Variants
42%
Rare Variants
38%
Gene Risk Score
38%
Genome-wide Association Study
38%
Head-and-neck Region
38%
ACE Inhibitors
33%
SLCO1B1
33%
Myotoxicity
33%
LILRB5
33%
Exome Sequencing
33%
Renin-angiotensin System
33%
Early Onset
33%
Statin Myalgia
33%
Angiotensin II Type 1 Receptor (AT1R)
33%
Myalgia
31%
Rhabdomyolysis
26%
Adverse Reactions
26%
Life-threatening
21%
Intolerant
18%
Hereditary Angioedema
16%
Rare Adverse Events
16%
Urticaria
16%
Patient Heterogeneity
16%
Genetic Etiology
16%
International Consortium
16%
Statin-induced Myopathy
16%
Single nucleotide Polymorphism
14%
RNA-binding Protein
14%
Scotland
14%
Cardiovascular Risk
11%
Myopathy
11%
Muscle Toxicity
11%
Standardized Nomenclature
11%
Idiopathic Inflammatory Myopathies
11%
Lipid-lowering Drugs
11%
High-risk Genes
9%
Caenorhabditis Elegans
9%
Odds Ratio
9%
Tayside
9%
Rosuvastatin
6%
Cardiovascular Outcomes
6%
Creatine Phosphokinase
6%
Electronic Medical Records
6%
Randomized Clinical Trial
6%
Lactate Dehydrogenase
6%
Risk Factors
6%
Non-adherent
6%
Genetic Variants
6%
Muscle Tissue
6%
Jupiter
6%
Immune System
6%
CK Elevation
6%
Leukocyte Immunoglobulin-like Receptor Subfamily B
6%
Genetic Groups
6%
Immunogenetics
6%
Pharmacology, Toxicology and Pharmaceutical Science
Statin (Protein)
100%
Angioneurotic Edema
66%
Myalgia
50%
Dipeptidyl Carboxypeptidase Inhibitor
44%
Myopathy
42%
Angiotensin Receptor Antagonist
40%
Rhabdomyolysis
35%
Angiotensin Receptor
33%
SLCO1B1
33%
Angiotensin
33%
Adverse Event
26%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
25%
Antilipemic Agent
16%
Cardiovascular Disease
16%
Urticaria
11%
Biochemistry, Genetics and Molecular Biology
Missense
75%
Statin
66%
Angiotensin-Converting Enzyme
62%
Enzyme Inhibitor
62%
Angiotensin Receptor
42%
Genome-Wide Association Study
37%
Exome Sequencing
33%
Angioedema
33%
Hereditary Angioedema
33%
SLCO1B1
33%
RNA-binding Protein
14%
Single-Nucleotide Polymorphism
14%
Genetics
10%
Caenorhabditis Elegans
9%
Fox
9%
Genetic Divergence
8%